The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Burykin I.M.

Kazan State Medical University, Pharmacology Department, Kazan, Russia

Aleeva G.N.

Kazan State Medical University, Pharmacology Department, Kazan, Russia

Khafiz'ianova R.Kh.

Kafedra farmakologii, kafedra khirurgicheskikh bolezneĭ #1 Kazanskogo gosudarstvennogo meditsinskogo universiteta;
Respublikanskaia klinicheskaia bol'nitsa, Kazan'

The analysis of compliance of pharmacotherapy of patients with myocardial infarction to the principles evidence-based medicine at the stage of rehabilitation in modern conditions

Authors:

Burykin I.M., Aleeva G.N., Khafiz'ianova R.Kh.

More about the authors

Read: 3221 times


To cite this article:

Burykin IM, Aleeva GN, Khafiz'ianova RKh. The analysis of compliance of pharmacotherapy of patients with myocardial infarction to the principles evidence-based medicine at the stage of rehabilitation in modern conditions. Problems of Balneology, Physiotherapy and Exercise Therapy. 2016;93(4):10‑19. (In Russ.)
https://doi.org/10.17116/kurort2016410-19

Recommended articles:
Possibilities of vibroacoustic therapy application in patients with chro­nic bronchopulmonary pathology. Problems of Balneology, Physiotherapy and Exercise Therapy. 2025;(1):12-18
Reha­bilitation of patients with post-COVID syndrome depe­nding on C(159)T poly­morphism of SD-14 gene. Problems of Balneology, Physiotherapy and Exercise Therapy. 2025;(1):42-50
Arti­ficial inte­lligence in comprehensive reha­bilitation of people with disa­bilities. (Literature review). Problems of Balneology, Physiotherapy and Exercise Therapy. 2025;(3):54-61
What we have to change in the treatment of ST-segment elevation myocardial infa­rction?. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(2):183-190

References:

  1. WHO. Disability-adjusted life years (DALYs). Whoint. 2016. Accessed: 13.12.2015. Available at: http://who.int/gho/mortality_burden_disease/daly_rates/en/
  2. Burykin I, Khafizianova R. The impact of social factors on mortality. Fundamental'nye issledovanija. 2015;(1):704-711. (In Russ.)
  3. Dawalji S, Venkateshwarlu K, Thota S, Venisetty PK, Venisetty RK. Prescribing pattern in coronary artery disease: a prospective study. Int J Pharm Res Rev. 2014;3(3):24-33.
  4. VNOK. Diagnosis and treatment of patients with acute myocardial infarction with ST segment of the electrocardiogram rise. Kardiovaskuljarnaja terapija i profilaktika. 2007;6(8,suppl.1):414-500. (In Russ.)
  5. Standart okazanija medicinskoj pomoshhi posle infarkta miokarda. Utverzhden prikazom Ministerstva zdravoohranenija i social'nogo razvitija Rossijskoj Federacii №230 ot 22.11.2004. Accessed 10.01.2012. Available at: https://www.rosminzdrav.ru (In Russ.)
  6. Perechen' zhiznenno neobhodimyh i vazhnejshih lekarstvennyh sredstv. Rasporjazhenie Pravitel'stva Rossijskoj Federacii №2343-r ot 29.12.2005. Accessed 01.01.2016. Available at: https://rg.ru/2006/01/13/lek-dok.html (In Russ.)
  7. Standart sanatorno-kurortnoj pomoshhi bol'nym s ishemicheskoj bolezn'ju serdca. Prikaz Ministerstva zdravoohranenija i social'nogo razvitija Rossijskoj Federacii №221 ot 22.11.2004. Accessed January 10, 2012. Available at: https://www.rosminzdrav.ru (In Russ.)
  8. Yudina I, Morozova T. Clinical use of fixed combinations of antihypertensive drugs. Lechashhij vrach. 2015;(2):8. (In Russ.)
  9. Khafizianova R, Burykin I, Aleeva G. Indicators in quality assessment of pharmacotherapy and health care. Vestnik Sankt-Peterburgskogo universiteta. Serija: 11. 2011;(4):103-112. (In Russ.)
  10. Aleeva G. Matematicheskaja statistika v jeksperimental'noj i klinicheskoj farmakologii. Kazan': Medicina; 2006. (In Russ.)
  11. Global'nyj plan dejstvij po profilaktike i kontrolju neinfekcionnyh zabolevanij na 2013-2020 gg. Zheneva, Shvejcarija: VOZ; 2014. (In Russ.)
  12. Laatikainen T, Critchley J, Vartiainen E, Salomaa V, Ketonen M, Capewell S. Explaining the decline in coronary heart disease mortality in Finland between 1982 and 1997. Am J Epidemiol. 2005;162(8):764-773.  doi:10.1093/aje/kwi274
  13. Posnenkova OM, Korotin AS, Kiselev AR, Gridnev VI, Belova OA, Rachkova SA, Romanchuk SV, Dovgalevsky PY, Oshchepkova EV. Performance of recommended measures on risk factors control in patients with hypertension, coronary artery disease and chronic heart failure: the data from 2014 Russian registry. Cardio-IT. 2015;2(1):e0102. doi:10.15275/cardioit.2015.0102
  14. Vere D. Errors of complex prescribing. Lancet. 1965;285(7381):370-373.  doi:10.1016/s0140-6736(65)91799-x
  15. Tasneem S, Fouzia N. Drug utilization study in ischemic heart diseases associated with diabetes and hypertension. Int J Pharma Bio Sci. 2010;1:1-4.
  16. Page RL, Ruscin JМ. The risk of adverse drug events and hospital-related morbidity and mortality among older adults with potentially inappropriate medication use. Am J Geriatr Pharmacother. 2006;4(4):297-305.  doi:10.1016/j.amjopharm.2006.12.008
  17. Aleeva G.N., Burykin I.M., Hafiz'janova R.H. Lekarstvennoe strahovanie kak odin iz putej uluchshenija okazanija medicinskoj pomoshhi naseleniju. Rossijskaja nauchno-prakticheskaja konferencija "Aktual'nye voprosy povyshenija kachestva dopolnitel'nogo professional'nogo obrazovanija farmacevticheskih kadrov"; mart 19, 2015; Kazan'. Accessed 01.01.2016. Available at: http://old.kazangmu.ru/files/PharmFPK/electron.pdf (In Russ.)
  18. Teslev A, Sorokin V, Minina S, Burakova M, Puchkova E. Modern metabolic cardiocytoprotectors. Technological aspects of drug development based on them. Nauchnye vedomosti BelGU. Serija: Medicina. Farmacija. 2014;175(4):188-195. (In Russ.)
  19. Lutai M, Lysenko A. Analysis of drug therapy for coronary heart disease in Ukraine: results of PULSAR Ukrainskij kardіologicheskij zhurnal. 2010;(3):36-43. (In Russ.)
  20. Khal'fin R, Kakorina E, Vorob'ev P, Luk'yantseva D. Clinical and economic matrix patient management plans as the basis for the calculation to ensure the health care costs. Problemy standartizatsii v zdravookhranenii. 2004;(9):3-17. (In Russ.)

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.